Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 11, 2021
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
Tue, August 10, 2021
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
[ Tue, Aug 10th 2021
] - WOPRAI
Vikram Purohit Downgraded (AXSM) to Hold and Decreased Target to $34 on, Aug 10th, 2021
Vikram Purohit of Morgan Stanley, Downgraded "Axsome Therapeutics, Inc." (AXSM) to Hold and Decreased Target from $105 to $34 on, Aug 10th, 2021.
Vikram has made no other calls on AXSM in the last 4 months.
There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Vikram
- Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021
